BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign

Gastroenterology. 2021 Nov;161(5):1715-1717.e1. doi: 10.1053/j.gastro.2021.06.076. Epub 2021 Jul 2.
No abstract available

MeSH terms

  • Adult
  • BNT162 Vaccine
  • COVID-19 / epidemiology
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines*
  • Case-Control Studies
  • Colitis, Ulcerative / drug therapy*
  • Crohn Disease / drug therapy*
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Israel / epidemiology
  • Male
  • Mass Vaccination
  • Middle Aged
  • Registries
  • Retrospective Studies
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • Immunologic Factors
  • BNT162 Vaccine

Supplementary concepts

  • COVID-19 breakthrough infections